SEC Form 4 · accession 0001179110-16-022256
Blueprint Medicines Corp · BPMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christoph Lengauer
Officer — Chief Scientific Officer
Period of report
Mar 24, 2016
Accepted (ET)
Mar 28, 2016 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 24, 2016 | M | 12,499 | $1.485 | A | 84,714 | D | |
| Common Stock | Mar 24, 2016 | M | 6,668 | $1.87 | A | 91,382 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.485 | Mar 24, 2016 | M | 12,499 | D | — | Nov 3, 2023 | Common Stock | 12,499 | 140,984 | D |
| Stock Option (Right to Buy)F2 | $1.87 | Mar 24, 2016 | M | 6,668 | D | — | Aug 14, 2024 | Common Stock | 6,668 | 134,316 | D |
Explanation of responses
- F1This option vests in 48 equal monthly installments beginning on November 1, 2013.
- F2This option vests in 48 equal monthly installments beginning on August 18, 2014.